Advocacy Actions

2019-02-27 > Beijing

Seminar with Center for Drug(Device) Re-evaluation on Adverse Events Reporting

The Chamber Healthcare Equipment Working Group was invited to attend the Seminar organized by NMPA to discuss three key Guidelines developed by Center for Drug(Device) Re-evaluation. Members' concerns and recommendations were raised by EUCCC HCE representatives, during the meeting.

Read more
2019-02-22 > All chapters

Meeting with Legislative Affairs Commission of the NPC Standing Committee and SCOFCOM on the Draft Foreign Investment Law

On February 22, 2019, the Legislative Affairs Committee of the Standing Committee of the National People's Congress and the Shanghai Municipal Commission of Commerce hosted a symposium to solicit opinions on the draft Foreign Investment Law. Representative of the European Chamber's Legal & Competition Working Group attended the symposium and presented members’ feedback and concerns.

Read more
2019-02-18 > Beijing

Attend CMDE Seminar on ICH Efficacy Guidelines

Attend Seminar of Center for Medical Device Evaluation on ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use) Efficacy Guidelines

Read more
2019-02-03 > Beijing

Comments to the CMDE's draft 'Master Document for Medical Device Registration'

The Healthcare Equipment (HCE) Working Group submitted comments to the Centre of Medical Device Evaluation's (CMDE) draft 'Master Document for Medical Device Registration'.

Read more
2019-02-03 > Beijing

Comments to the MoF's draft "Government Procurement Announcements and Information Release"

The Public Procurement Taskforce submitted comments to the Ministry of Finance's (MoF) draft "Government Procurement Announcements and Information Release".

Read more
2019-01-23 > Beijing

Comments to the SAMR's "Supervision of Agents for Imported Medical Devices" Public Consultation

On 24th December 2018, State Administration of Market Regulation (SAMR) published the second draft of Supervision of Agents for Imported Medical Devices.

Read more
2019-01-17 > Beijing

Meeting with the National Institutes for Food and Drug Control on the 2019 Development Plan for IVD Standards

The Healthcare Equipment (HCE) Working Group hold a meeting with the National Institutes for Food and Drug Control (NIFDC) and the Institute for Medical Device Standardisation on the 2019 development plan for in vitro diagnostics (IVD) standards.

Read more
2019-01-16 > Beijing

update the Key Market Access Barrier List for China, for medical device sector

Feedback to Delegation of the European Union to China (EUD) regarding the European Commission on Key Market Access Barrier List for China, for medical device sector

Read more
2019-01-07 > Beijing

Seminar on New Hospital Payment Systems

The Healthcare Equipment (HCE) Working Group hold a seminar on Diagnostic Related Groups (DRG), a new Payment System for Hospital Services.

Read more
2018-12-29 > Beijing

Comments to the CDR’s “Guideline for the Formatting of the Regular Risk Assessment Report by the Medical Devices (MAH)”

On 27 November 2018, the Centre for Drug Re-evaluation has initiated a public consultation on “Guideline for the Formatting of the Regular Risk Assessment Report by the Medical Devices (MAH)”.

Read more